There are errors in the Funding section. The correct funding information is as follows: This work was supported by National Institute of Health Research Grants R01DE10742 and R01DE14183, and The Mary Kay Foundation Research Grant number 005–13 (to DKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Reference
Citation: Lee Y-H, Liu X, Qiu F, O’Connor TR, Yen Y, Ann DK (2015) Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy. PLoS ONE 10(4): e0124853. https://doi.org/10.1371/journal.pone.0124853
Published: April 13, 2015
Copyright: © 2015 Lee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited